GB Patent

GB1348642A — Hypocholesterolaemic compositions

Assigned to Individual · Expires 1974-03-20 · 52y expired

What this patent protects

1348642 Hypocholesterolaemic composition A N HOWARD 13 Oct 1971 [15 Oct 1970] 49140/70 Heading ASB A hypocholesterolaemic composition comprises (a) a compound of formula in which R<SP>1</SP> and R<SP>2</SP> are separately H or C 1-6 alkyl or together with…

USPTO Abstract

1348642 Hypocholesterolaemic composition A N HOWARD 13 Oct 1971 [15 Oct 1970] 49140/70 Heading ASB A hypocholesterolaemic composition comprises (a) a compound of formula in which R<SP>1</SP> and R<SP>2</SP> are separately H or C 1-6 alkyl or together with the carbon atom to which they are linked represent a cycloalkyl radical, R<SP>3</SP> is phenyl or α-naphthyl optionally substituted with up to 3 halo, alkyl, alkenyl, alkoxy, aryl, alkaryl, aralkyl, aralkoxy or arylamino groups, X is O or NH, Y is an amino group or a group Z and Z is H, a cation or a residue of an esterified alcohol ZOH and (b) an anion exchange resin, the weight ratio (a):(b) being from 1:6 to 1:20. Component (a) may be α-(4-chlorophenoxy) isobutyric acid, α- (4-ethylphenoxy) isobutyric acid or a sodium, potassium, calcium, magnesium, iron or aluminium salt or a methyl, ethyl or n-propyl ester thereof. The ion-exchange resin may be (a) an #-aminoalkyl ether, #-dialkylaminoalkyl ether, #-guanidinoalkyl ether or #-p-aminophenylalkyl ether of dextran or cellulose cross-linked with epichlorohydrin, all alkyl groups having 1 to 4 carbon atoms, (b) a condensation polymer of a poly(ethylene imine) and epichlorohydrin, glycerol, 1,3-dichlorohydrin or an aliphatic bis-epoxy compound, (c) a styrene divinyl benzene copolymer containing quaternary ammonium groups or (d) an addition polymer of a compound of formula in which R is H, methyl, phenyl, carboxylic acid, methoxycarbonyl or ethoxycarbonyl, R' is methyl or -CH 2 COOX wherein X is H or C 1-4 alkyl and Z is pyridinium or a carboxylic ester group which includes a quaternary ammonium group but is free of aliphatic unsaturation. The composition may also include taurine and a carrier. It may be in the form of powder, tablets, capsules, an oil suspension or an aqueous suspension. Component (a) may be separately enclosed in microcapsules.

Drugs covered by this patent

Patent Metadata

Patent number
GB1348642A
Jurisdiction
GB
Classification
Expires
1974-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.